MAGNETOM RT Pro edition for MAGNETOM Vida
The time is now for MR in RT – with BioMatrix.
MRI utilization in RT treatment planning continues to see steady growth. Between 2006 and 2016 its utilization increased from 6% to 25%.1
The MAGNETOM RT Pro edition for MAGNETOM Vida, the first MR scanner with BioMatrix Technology, addresses the challenges of patient variability for radiation therapy treatment planning.
Thanks to a new magnet and system architecture, MAGNETOM Vida delivers excellent soft-tissue contrast as well as imaging that can yield information for physicians regarding tumor extent and functional parameters. It can add substantial value to radiotherapy and helps advance your institution’s clinical capabilities by efficiently integrating this additional modality into existing processes.
IMV Medical Information Division – 2017 Radiation Therapy Market Summary Report.